Fukuta Y - Search Results

1

[Effect of liver hydrolysate on hepatic proliferation in regenerating rat liver].

Fukuda Y, Sawata M, Washizuka M, Higashino R, Fukuta Y, Tanaka Y, Takei M. Fukuda Y, et al. Among authors: fukuta y. Nihon Yakurigaku Zasshi. 1999 Oct;114(4):233-8. doi: 10.1254/fpj.114.233. Nihon Yakurigaku Zasshi. 1999. PMID: 10584237 Japanese.

2

A new thromboxane receptor antagonist, Z-335, ameliorates experimental thrombosis without prolonging the rat tail bleeding time.

Tanaka T, Ito S, Higashino R, Fukuta Y, Fukuda Y, Takei M, Kurimoto T, Tamaki H. Tanaka T, et al. Among authors: fukuta y. Thromb Res. 1998 Sep 1;91(5):229-35. doi: 10.1016/s0049-3848(98)00103-0. Thromb Res. 1998. PMID: 9755835

3

Antiplatelet effect of Z-335, a new orally active and long-lasting thromboxane receptor antagonist.

Tanaka T, Fukuta Y, Higashino R, Sato R, Nomura Y, Fukuda Y, Ito S, Takei M, Kurimoto T, Tamaki H. Tanaka T, et al. Among authors: fukuta y. Eur J Pharmacol. 1998 Sep 11;357(1):53-60. doi: 10.1016/s0014-2999(98)00540-8. Eur J Pharmacol. 1998. PMID: 9788773

4

Z-350, a novel compound with alpha 1-adrenoceptor antagonistic and steroid 5 alpha-reductase inhibitory actions: pharmacological properties in vivo.

Fukuta Y, Fukuda Y, Higashino R, Yoshida K, Ogishima M, Tamaki H, Takei M. Fukuta Y, et al. J Pharmacol Exp Ther. 1999 Sep;290(3):1013-8. J Pharmacol Exp Ther. 1999. PMID: 10454472

5

Hormonal effects of Z-350, possessing steroid 5alpha-reductase inhibitory and alpha1-adrenoceptor antagonistic actions, in the rat.

Fukuda Y, Fukuta Y, Higashino R, Yoshida K, Ogishima M, Takei M, Kurimoto T. Fukuda Y, et al. Among authors: fukuta y. Jpn J Pharmacol. 2001 Jul;86(3):323-8. doi: 10.1254/jjp.86.323. Jpn J Pharmacol. 2001. PMID: 11488433 Free article.

6

Arachidonic acid-induced hind limb gangrene: a new experimental rat model of peripheral vascular disease.

Tanaka T, Takei M, Fukuta Y, Higashino R, Fukuda Y, Nomura Y, Ito S, Tamaki H, Kurimoto T, Suzuki Y. Tanaka T, et al. Among authors: fukuta y. Biol Pharm Bull. 1999 Mar;22(3):257-60. doi: 10.1248/bpb.22.257. Biol Pharm Bull. 1999. PMID: 10220280 Free article.

7

Z-350, a new chimera compound possessing alpha1-adrenoceptor antagonistic and steroid 5alpha-reductase inhibitory actions.

Fukuda Y, Fukuta Y, Higashino R, Ogishima M, Yoshida K, Tamaki H, Takei M. Fukuda Y, et al. Among authors: fukuta y. Naunyn Schmiedebergs Arch Pharmacol. 1999 Jun;359(6):433-8. doi: 10.1007/pl00005372. Naunyn Schmiedebergs Arch Pharmacol. 1999. PMID: 10431752

8

Z-335, a thromboxane A2 receptor antagonist, suppresses the progression of arachidonic acid-induced hind limb gangrene in rats.

Tanaka T, Fukuta Y, Fukuda Y, Higashino R, Ito S, Takei M, Tamaki H, Kurimoto T, Suzuki Y. Tanaka T, et al. Among authors: fukuta y. Biol Pharm Bull. 1999 Dec;22(12):1382-4. doi: 10.1248/bpb.22.1382. Biol Pharm Bull. 1999. PMID: 10746175 Free article.

9

Pharmacodynamic analysis of steroid 5alpha-reductase inhibitory actions of Z-350 in rat prostate.

Furuta S, Fukuda Y, Sugimoto T, Miyahara H, Kamada E, Sano H, Fukuta Y, Takei M, Kurimoto T. Furuta S, et al. Among authors: fukuta y. Eur J Pharmacol. 2001 Aug 24;426(1-2):105-11. doi: 10.1016/s0014-2999(01)01208-0. Eur J Pharmacol. 2001. PMID: 11525778

10

Dual-acting agents with alpha1-adrenoceptor antagonistic and steroid 5alpha-reductase inhibitory activities. Synthesis and evaluation of arylpiperazine derivatives.

Sato H, Kitagawa O, Aida Y, Chikazawa J, Kurimoto T, Takei M, Fukuta Y, Yoshida K. Sato H, et al. Among authors: fukuta y. Bioorg Med Chem Lett. 1999 Jun 7;9(11):1553-8. doi: 10.1016/s0960-894x(99)00230-9. Bioorg Med Chem Lett. 1999. PMID: 10386934

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

172 results

Search Page

Filters